Liquid Biopsy For Cancer Diagnostics Global Market Opportunities And Strategies To 2034

Description

Liquid biopsy for cancer diagnostics refers to a minimally invasive technique that enables the detection and monitoring of cancer through the analysis of biomarkers present in body fluids such as blood, urine, or saliva. This diagnostic approach is increasingly transforming cancer care by offering a less invasive alternative to traditional tissue biopsies, which often require surgical procedures.

The liquid biopsy for cancer diagnostics market consists of sales, by entities (organizations, sole traders and partnerships) of liquid biopsy for cancer diagnostics products and services that are utilized by healthcare professionals for early cancer detection, tracking disease progression, monitoring treatment efficacy and detecting recurrence. These diagnostic tools are especially advantageous for cases where tissue biopsy is challenging or impossible, such as in advanced-stage cancers or when monitoring for residual disease.

The global liquid biopsy for cancer diagnostics market was valued at $4,446.47 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 15.00%.

Government Initiatives For Research And Development In Healthcare

Government initiatives for research and development in healthcare supported the growth of the liquid biopsy for cancer diagnostics market during the historic period. Government initiatives refer to specific actions, programs, policies, or projects undertaken by government authorities at various levels (local, regional, national, or international) to address specific issues, achieve certain goals, or create positive changes in society. Government initiatives for research and development provide critical support for advancing liquid biopsy for cancer diagnostics by fostering innovation, collaboration, regulatory oversight, public awareness, access to healthcare services and data sharing. For instance, in November 2023, the UK and France announced a partnership to tackle significant challenges in cancer research. This collaboration between France's Institut National Du Cancer (INCa), a French national cancer institute and Cancer Research UK, a leading charity that funds research into all types of cancer in the UK, is dedicated to funding leading experts to address the most complex cancer cases. Together, they will contribute £8.6 million ($10.8 million) to support the global Cancer Grand Challenges initiative and advance world-class cancer research efforts. Therefore, government initiatives for research and development in healthcare supported the growth of the liquid biopsy for cancer diagnostics market.

High-Precision Liquid Biopsy For Identifying Cancer Biomarkers

Major companies operating in the liquid biopsy for cancer diagnostics market are focusing on developing high-precision liquid biopsy for identifying cancer biomarkers. High-precision liquid biopsy refers to advanced techniques used to analyze circulating biomarkers in bodily fluids, primarily blood, to detect and monitor cancer with a high degree of accuracy. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics software and services provider, launched the somatic advantage 74 Liquid Biopsy (SA74 LB) test. This high-precision liquid biopsy test detects circulating tumor deoxyribonucleic acid (ctDNA) in blood samples from cancer patients, analyzing 74 clinically significant genes to offer valuable insights for treatment decisions. The SA74 LB test is designed to be minimally invasive, requiring only a blood sample, thus providing a more convenient alternative to traditional tissue biopsies. Utilizing Unique Molecular Identifiers (UMIs) ensures high-accuracy detection of genetic variants, enabling clinicians to identify potential biomarkers and optimize treatment strategies effectively.

The global liquid biopsy for cancer diagnostics market is fairly fragmented, with a large number of small players in the market. The top ten competitors in the market made up 24.44% of the total market in 2023.

Liquid Biopsy For Cancer Diagnostics Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global liquid biopsy for cancer diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for liquid biopsy for cancer diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The liquid biopsy for cancer diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider liquid biopsy for cancer diagnostics market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by cancer, by sample and by end user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the liquid biopsy for cancer diagnostics market.
Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis -Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by cancer, by end user and by sample in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for liquid biopsy for cancer diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Product; Services
2) By Cancer: Lung Cancer; Breast Cancer; Colon Cancer; Other Cancers
3)By Sample: Blood; Urine; Saliva
4) By End User: Hospitals; Diagnostic Centers; Other End Users
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Guardant Health Inc.; Illumina Inc.; Exact Sciences Corporation
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; liquid biopsy for cancer diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1496

1 Executive Summary

1.1 Liquid Biopsy For Cancer Diagnostics - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Liquid Biopsy For Cancer Diagnostics Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Product
- 6.4.2 Services
6.5 Market Segmentation By Cancer
- 6.5.1 Lung Cancer
- 6.5.2 Breast Cancer
- 6.5.3 Colon Cancer
- 6.5.4 Other Cancers
6.6 Market Segmentation By Sample
- 6.6.1 Blood
- 6.6.2 Urine
- 6.6.3 Saliva
6.7 Market Segmentation By End User
- 6.7.1 Hospitals
- 6.7.2 Diagnostic Centers
- 6.7.3 Other End Users

7 Major Market Trends

7.1 High-Precision Liquid Biopsy For Identifying Cancer Biomarkers
7.2 Advancements In Automated Liquid Biopsy Technologies For Oncology And Prenatal Care
7.3 Next-Generation Liquid Biopsy Tool Improves Cancer Screening Capabilities
7.4 Technological Advancement In Liquid Biopsy For Personalized Cancer Treatment
7.5 Enhancing Tumor Detection And Profiling With Liquid Biopsy

8 Liquid Biopsy For Cancer Diagnostics Market - Macro-Economic Scenario

8.1 COVID-19 Impact On The Liquid Biopsy For Cancer Diagnostics Market
8.2 Impact Of The War In Ukraine On The Liquid Biopsy For Cancer Diagnostics Market
8.3 Impact Of High Inflation On The Liquid Biopsy For Cancer Diagnostics Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 9.2.1 Market Drivers 2019 - 2024
- 9.2.2 Market Restraints 2019- 2024
9.3 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
- 9.3.1 Market Drivers 2024 - 2029
- 9.3.2 Market Restraints 2024 - 2029

10 Global Liquid Biopsy For Cancer Diagnostics Market Segmentation

10.1 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.3 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.4 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Liquid Biopsy For Cancer Diagnostics Market, Regional and Country Analysis

11.1 Global Liquid Biopsy For Cancer Diagnostics Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.2 Global Liquid Biopsy For Cancer Diagnostics Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate Tax Structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
12.7 China Market
12.8 Summary
12.9 Market Overview
- 12.9.1 Country Information
- 12.9.2 Market Information
- 12.9.3 Background Information
- 12.9.4 Government Initiatives
- 12.9.5 Regulations
- 12.9.6 Regulatory Bodies
- 12.9.7 Major Associations
- 12.9.8 Taxes Levied
- 12.9.9 Corporate Tax Structure
- 12.9.10 Investments
- 12.9.11 Major Companies
12.10 China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.12 China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 India Market
12.14 India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.16 India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 Japan Market
12.18 Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.20 Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Australia Market
12.22 Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.24 Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Indonesia Market
12.26 Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.27 Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.28 Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.29 South Korea Market
12.30 South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.31 South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.32 South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Western Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate tax structure
- 13.2.10 Investments
- 13.2.11 Major Companies
13.3 Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Western Europe Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
13.7 UK Market
13.8 UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.11 Germany Market
13.12 Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.13 Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.14 Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.15 France Market
13.16 France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.17 France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.18 France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.19 Italy Market
13.20 Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.21 Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.22 Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.23 Spain Market
13.24 Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.25 Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.26 Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Major companies
14.3 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
14.7 Russia Market
14.8 Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.9 Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.10 Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 North America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
15.3 North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 North America Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
- 15.9.1 Country Information
- 15.9.2 Market Information
- 15.9.3 Background Information
- 15.9.4 Government Initiatives
- 15.9.5 Regulations
- 15.9.6 Regulatory Bodies
- 15.9.7 Major Associations
- 15.9.8 Taxes Levied
- 15.9.9 Corporate Tax Structure
- 15.9.10 Investments
- 15.9.11 Major Companies
15.10 USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.11 USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.12 USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.13 Canada Market
15.14 Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.15 Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.16 Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 South America Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Major Companies
16.3 South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.6 South America Liquid Biopsy For Cancer Diagnostics Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.9 Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.10 Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Middle East Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
17.3 Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Africa Market

18.1 Summary
18.2 Market Overview
- 18.2.1 Region Information
- 18.2.2 Market Information
- 18.2.3 Background Information
- 18.2.4 Government Initiatives
- 18.2.5 Regulations
- 18.2.6 Regulatory Bodies
- 18.2.7 Major Associations
- 18.2.8 Taxes Levied
- 18.2.9 Corporate Tax Structure
- 18.2.10 Major Companies
18.3 Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.4 Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18.5 Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles
19.2 F. Hoffman-La Roche Ltd
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
19.3 Thermo Fisher Scientific Inc
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
19.4 Guardant Health Inc
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
19.5 Illumina Inc.
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Financial Overview
19.6 Exact Sciences Corporation
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial Overview

20 Other Major And Innovative Companies

20.1 Natera Inc.
- 20.1.1 Company Overview
- 20.1.2 Products And Services
20.2 Johnson & Johnson Services Inc.
- 20.2.1 Company Overview
- 20.2.2 Products And Services
20.3 Bio-Rad Laboratories Inc.
- 20.3.1 Company Overview
- 20.3.2 Products And Services
20.4 Caris Life Science
- 20.4.1 Company Overview
- 20.4.2 Products And Services
20.5 Sysmex Corporation
- 20.5.1 Company Overview
- 20.5.2 Products And Services
20.6 Qiagen NV
- 20.6.1 Company Overview
- 20.6.2 Products And Services
20.7 Myriad Genetic Laboratories Inc.
- 20.7.1 Company Overview
- 20.7.2 Products And Services
20.8 Invitae Corporation
- 20.8.1 Company Overview
- 20.8.2 Products And Services
20.9 Freenome Holdings Inc.
- 20.9.1 Company Overview
- 20.9.2 Products And Services
20.1 Tempus Labs, Inc.
- 20.10.1 Company Overview
- 20.10.2 Products And Services
20.11 MDxHealth SA
- 20.11.1 Company Overview
- 20.11.2 Products And Services
20.12 NeoGenomics Laboratories Inc.
- 20.12.1 Company Overview
- 20.12.2 Products And Services
20.13 ExosomeDx
- 20.13.1 Company Overview
- 20.13.2 Products And Services
20.14 Biodesix Inc.
- 20.14.1 Company Overview
- 20.14.2 Products And Services
20.15 Biocartis Group NV.
- 20.15.1 Company Overview
- 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 Quest Diagnostics Acquired Haystack Oncology
23.2 Exact Sciences Corporation Acquired Resolution Bioscience, Inc.
23.3 Exact Sciences Corporation Acquired Thrive Earlier Detection

24 Opportunities And Strategies

24.1 Global Liquid Biopsy For Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Liquid Biopsy For Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Liquid Biopsy For Cancer Diagnostics Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Liquid Biopsy For Cancer Diagnostics Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer